Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer

1 Jul 2019

Abstract excerpt

Background: Gastric cancer is still a common cancer worldwide. Investigation of potential plasma biomarkers for gastric cancer diagnosis is essential for prevention strategies and early intervention for gastric cancer-control planning. Objectives: This study was aimed to explore the lncRNAs’ promoter of CDKN1A antisense DNA-damage-activated RNA (PANDAR), FOXD2-AS1, and SMARCC2 as potential novel diagnostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31308753
DOI: 10.2147/cmar.s201935

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancerPMID 31308753Read ↗

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistanceSemantic proximity Read ↗

Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.Semantic proximity Read ↗

Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancerSemantic proximity Read ↗

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancerSemantic proximity Read ↗

Long noncoding RNAs in gastric cancer: From molecular dissection to clinical applicationSemantic proximity Read ↗

Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosisSemantic proximity Read ↗

Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric CancerSemantic proximity Read ↗

Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studiesSemantic proximity Read ↗

Functional long non-coding RNAs associated with gastric cancer susceptibility and evaluation of the epidemiological efficacy in a central Chinese population.Semantic proximity Read ↗

Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysisSemantic proximity Read ↗

Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implicationsSemantic proximity Read ↗

Emerging role of long non-coding RNA in the development of gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.